Intrinsiqq
YD Bio Limited logo

YD Bio Limited Intrinsic Value

YDES

Compare

Choose a model

Each card values YD Bio a different way, shown at our starting inputs. Pick one to see and change how it works.

Set your assumptions

YD Bio on revenue: sales per share grow and the stock trades at a normal price-to-sales multiple. For companies not yet profitable.

Years to project

Growth of revenue per share

Revenue per share; not enough history; starts at 5%

Exit P/S

Starts at its industry's median P/S

Your desired return

Margin of safety

More

Your buy price

The expected return is measured from it; starts at today's price

How it's worked out

  1. Today's revenue per share

    Last twelve months

    $0.01

  2. Revenue in 2031

    Grows 5.0% a year for 5 years

    $0.01

  3. Price in 2031

    $0.01 × 2.3 P/S

    $0.03

  4. Worth today

    ÷ 1.10^5: your 10% a year, taken back out

    $0.02

  5. Fair value

    The most you can pay and still earn 10% a year

    $0.02

  6. Buy below

    Fair value minus your 25% margin of safety

    $0.01

Paying $4.83 instead gives -64.8% a year. Every rule is on the methodology page.

Outcome

What your assumptions give, and the path from today's price.

Fair value

$0.02

Expected return

-64.8% a year

Future price, 2031

$0.03

Buy below

$0.01

Price 29524% above fair valuePrice $4.83, at your 10% return

Projection

Solid blue: the price at each year end. Dashed blue: from today's price to the 2031 price. Green: from the fair value, rising at your 10% a year to the same end point; buy at or below it and you earn at least that. Every rule is on the methodology page. A model, not a forecast or advice.

YD Bio (YDES) intrinsic value and fair value

The calculator grows one of YD Bio's per-share figures (earnings, free cash flow, revenue, book value or dividends) for a few years, puts an exit multiple on it, and discounts the result back at the yearly return you want. The answers below use its starting inputs for YDES; this is analysis, not investment advice.

Frequently asked

What is YD Bio's (YDES) intrinsic value?+

With Intrinsiqq's starting inputs, YD Bio's fair value is about $0.02 a share, based on its revenue per share. That assumes revenue per share of $0.01 grows about 5.0% a year for 5 years, the stock then trades at 2.3 times revenue, and you want a 10.0% yearly return. Every input can be changed on the page; the result is a model, not a forecast.

Is YD Bio overvalued?+

At $4.83, the price is 29524% above that fair value of $0.02, and buying at today's price would return about -64.8% a year if those inputs hold. Whether that is cheap or dear depends on whether you believe the growth and the exit multiple, which is what the calculator lets you test. This is analysis from company filings, not investment advice.

What growth does the YD Bio valuation assume?+

Revenue per share grows about 5.0% a year to start, a default, because there is too little history. The exit multiple starts at its industry's median.

What is a good margin of safety for YD Bio?+

A margin of safety is the cushion you want below the fair value before buying, in case the inputs are wrong. The calculator uses 25%, which puts the buy-below price at $0.01. Less predictable businesses deserve a wider cushion, or a higher desired return.

How the market compares: US profitability statistics

Peers

Biotechnology · Pick stocks to compare with YDES

CompareIntrinsic value
PROGEN.XSTOProstatype Genomics AB
€0.01+3.45%10
OXUR.XBRUOxurion NV
€0.00+0.00%15
ITOCPheton Holdings Ltd.
$1.59+6.00%18
ATORX.XSTOAlligator Bioscience AB
kr 0.01-5.68%10
TNG.XPARTransgene SA
€0.69+0.43%10
NANECH.XSTONanoEcho AB
No recent price10
BIBB.XSTOBibbinstruments AB
€0.03+7.69%10
TANAFTian'an Technology Group Ltd.
$0.10+0.00%61

Held by ETFs

YDES is in 1 US ETF. The largest of them, with YDES's weight in each:

Spot a number that looks wrong?

Download this analysis as a PDF (Pro)

Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing YDES

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.